An expert discusses how comprehensive genomic profiling using both tissue and liquid samples has become essential for personalized cancer care, particularly in lung cancer, where dual testing strategies can identify actionable mutations, guide treatment selection, and monitor resistance to improve patient outcomes.
EP. 1: Comprehensive Genomic Profiling Is a Cornerstone of Cancer Care
July 10th 2025An expert discusses how molecular profiling has become essential for most solid tumor cancers, particularly in lung cancer, where both tissue- and plasma-based testing using next-generation sequencing help identify actionable genomic targets and monitor resistance patterns.
EP. 2: Putting Comprehensive Genomic Profiling into Practice With Advanced Lung Cancer
July 10th 2025An expert discusses how molecular profiling has become essential for most solid tumor cancers, particularly in lung cancer, where both tissue- and plasma-based testing using next-generation sequencing help identify actionable genomic targets and monitor resistance patterns.
EP. 4: Key Insights for Improving Adoption of Dual and Concurrent Testing for Cancer Care
July 10th 2025An expert discusses how education about the clinical impact of genomic testing, understanding of targeted therapies, turnaround times, and team-based approaches are essential to bridge the gap in routine comprehensive genomic profiling adoption.
EP. 5: What’s Next for Comprehensive Genomic Profiling in Cancer Care
July 10th 2025An expert discusses how comprehensive genomic profiling will continue growing as an essential component of personalized cancer care, expanding into serial testing for resistance monitoring, tumor burden tracking, and potentially earlier-stage cancers as targeted therapies prove effective beyond advanced disease.